Proof-of-concept double-blind, placebo-controlled, randomized clinical trial with nilotinib in spondyloarthritis

Update Il y a 4 ans
Reference: EUCTR2010-023185-42

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess the clinical efficacy and safety of tyrosine kinase inhibition by nilotinib in spondyloarthritis


Inclusion criteria

  • Active axial and peripheral spondyloarthritis

Links